Phase 2 Study to Assess the Safety and Efficacy of ANG003
for Exocrine Pancreatic Insufficiency (EPI)
26 locations incl. Long Beach
Sponsor: Anagram Therapeutics, Inc.
Sex: All·Age: 12+
Code: NCT07450547·Phase 2·Recruiting·Listed Mar 2026
University of Florida - Archer
Clinical research site in Gainesville, Florida · 1600 SW ARCHER RD, ROOM D2-11, GAINESVILLE, FL 32610-3003 · (352) 395-8013
As of July 2026, 227 paid clinical trials are recruiting at University of Florida - Archer in Gainesville, Florida. Active studies at this site cover conditions such as Parkinson Disease and Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at University of Florida - Archer (227)
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for CRC (Colorectal Cancer)
67 locations incl. Tucson
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07284849·Phase 3·Recruiting·Listed Dec 2025
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
for Metabolic Dysfunction Associated Steatohepatitis (MASH)
163 locations incl. Birmingham
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06632444·Phase 3·Recruiting·Listed Oct 2024
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for Carcinoma, Non-Small-Cell Lung
129 locations incl. Daphne
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
for Parkinson Disease
45 locations incl. Sun City
Sponsor: Neuron23 Inc.
Sex: All·Age: 40 - 80
Code: NCT06680830·Phase 2·Recruiting·Listed Nov 2024
Fabry Disease Registry & Pregnancy Sub-registry
for Fabry Disease
74 locations incl. Birmingham
Sponsor: Genzyme, a Sanofi Company
Sex: All·Age: All ages
Code: NCT00196742·Recruiting·Listed Sep 2005
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
for Pain
12 locations incl. Greenwood Village
Sponsor: Boston Scientific Corporation
Sex: All·Age: 18+
Code: NCT01719055·Recruiting·Listed Nov 2012
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for Glioma
42 locations incl. Birmingham
Sponsor: Nuvation Bio Inc.
Sex: All·Age: 18+
Code: NCT05303519·Phase 3·Recruiting·Listed Mar 2022
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
for Parkinson Disease
27 locations incl. Phoenix
Sponsor: AskBio Inc
Sex: All·Age: 45 - 75
Code: NCT06285643·Phase 2·Recruiting·Listed Feb 2024
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
for Immunoglobulin A Nephropathy (IgAN)
24 locations incl. Little Rock
Sponsor: Biogen
Sex: All·Age: 18+
Code: NCT06935357·Phase 3·Recruiting·Listed Apr 2025
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
for Type 1 Diabetes Mellitus
33 locations incl. Tucson
Sponsor: COUR Pharmaceutical Development Company, Inc.
Sex: All·Age: 12 - 35
Code: NCT06783309·Phase 1, Phase 2·Recruiting·Listed Jan 2025
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
for Relapsing Multiple Sclerosis
40 locations incl. Scottsdale
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 40 - 70
Code: NCT06846281·Phase 3·Recruiting·Listed Feb 2025
Tracking Results of Ablations to Combat AF Registry Generation 2
for Atrial Fibrillation
26 locations incl. Huntsville
Sponsor: AtriCure, Inc.
Sex: All·Age: 18+
Code: NCT05111015·Recruiting·Listed Nov 2021
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for Pulmonary Hypertension Due to Lung Diseases and Hypoxia
66 locations incl. Birmingham
Sponsor: United Therapeutics
Sex: All·Age: 18+
Code: NCT06388421·Recruiting·Listed Apr 2024
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
for Pulmonary Embolism
55 locations incl. Long Beach
Sponsor: Penumbra Inc.
Sex: All·Age: 18+
Code: NCT04798261·Recruiting·Listed Mar 2021
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
for Lewy Body Dementia Psychosis
25 locations incl. Irvine
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All·Age: 55 - 84
Code: NCT07029581·Phase 2·Recruiting·Listed Jun 2025
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
for Lower Extremity Acute Limb Ischemia
31 locations incl. Scottsdale
Sponsor: Penumbra Inc.
Sex: All·Age: 18+
Code: NCT06747117·Recruiting·Listed Dec 2024
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
for Alpha1-Antitrypsin Deficiency
33 locations incl. Birmingham
Sponsor: Takeda
Sex: All·Age: 18 - 75
Code: NCT05677971·Phase 3·Recruiting·Listed Jan 2023
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
for Aortoiliac Occlusive Disease
23 locations incl. Long Beach
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18+
Code: NCT05811364·Recruiting·Listed Apr 2023
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for High-Risk Non-Muscle-Invasive Bladder Cancer
61 locations incl. Phoenix
Sponsor: CG Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06567743·Phase 2·Recruiting·Listed Aug 2024
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
for Parkinson's Disease
18 locations incl. Los Angeles
Sponsor: Boston Scientific Corporation
Sex: All·Age: 18+
Code: NCT02071134·Recruiting·Listed Feb 2014
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
for Type 2 Diabetes Mellitus
58 locations incl. Huntsville
Sponsor: Prokidney
Sex: All·Age: 30 - 80
Code: NCT05099770·Phase 3·Recruiting·Listed Oct 2021
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
for Critical Limb Ischemia
8 locations incl. Gainesville
Sponsor: LimFlow, Inc.
Sex: All·Age: 18 - 95
Code: NCT05313165·Recruiting·Listed Apr 2022
Registry for Stage 2 Type 1 Diabetes
for Type 1 Diabetes
37 locations incl. Los Angeles
Sponsor: Sanofi
Sex: All·Age: All ages
Code: NCT06481904·Recruiting·Listed Jul 2024
Zenith® Fenestrated+ Clinical Study
for Aortic Aneurysm, Abdominal
30 locations incl. Birmingham
Sponsor: Cook Research Incorporated
Sex: All·Age: 18+
Code: NCT04875429·Recruiting·Listed May 2021
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis
38 locations incl. Sun City
Sponsor: Gilead Sciences
Sex: All·Age: 18 - 75
Code: NCT06029972·Phase 2·Recruiting·Listed Sep 2023
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
for Acute Decompensated Heart Failure
37 locations incl. Irvine
Sponsor: Reprieve Cardiovascular, Inc
Sex: All·Age: 22+
Code: NCT06898515·Phase 3·Recruiting·Listed Mar 2025
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
for Esophageal Stricture
34 locations incl. Birmingham
Sponsor: GIE Medical
Sex: All·Age: 22+
Code: NCT05561114·Phase 3·Recruiting·Listed Sep 2022
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
for Bowel
33 locations incl. Scottsdale
Sponsor: GIE Medical
Sex: All·Age: 22+
Code: NCT05561127·Phase 3·Recruiting·Listed Sep 2022
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
for Multiple Myeloma (MM)
20 locations incl. Gilbert
Sponsor: C4 Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07280013·Phase 1·Recruiting·Listed Dec 2025
AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Safety and Performance of The ECLIPSIUM System for Mesh Fixation IDE
for Hernia
12 locations incl. Loma Linda
Sponsor: Tissium
Sex: All·Age: 22+
Code: NCT07277946·Recruiting·Listed Dec 2025
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
for Type 1 Diabetes Mellitus
10 locations incl. Los Angeles
Sponsor: Mannkind Corporation
Sex: All·Age: 10 - 17
Code: NCT07224321·Phase 2·Recruiting·Listed Nov 2025
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
for Aortic Arch Aneurysm
21 locations incl. Birmingham
Sponsor: Artivion Inc.
Sex: All·Age: 18 - 80
Code: NCT07089576·Recruiting·Listed Jul 2025
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
for Vascular Disease
24 locations incl. Tucson
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18+
Code: NCT06658730·Recruiting·Listed Oct 2024
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
for Aortic Dissection
18 locations incl. Birmingham
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18+
Code: NCT06827990·Recruiting·Listed Feb 2025
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
for Gastrointestinal Cancer
8 locations incl. Aurora
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06596694·Phase 1, Phase 2·Recruiting·Listed Sep 2024
4D-710 in Adult Patients With Cystic Fibrosis
for Cystic Fibrosis Lung
18 locations incl. Birmingham
Sponsor: 4D Molecular Therapeutics
Sex: All·Age: 18+
Code: NCT05248230·Phase 2·Recruiting·Listed Feb 2022
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
for Duchenne Muscular Dystrophy
13 locations incl. Little Rock
Sponsor: REGENXBIO Inc.
Sex: Male·Age: 1+
Code: NCT05693142·Phase 2, Phase 3·Recruiting·Listed Jan 2023
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
for Idiopathic Pulmonary Fibrosis
15 locations incl. Birmingham
Sponsor: Boehringer Ingelheim
Sex: All·Age: 40+
Code: NCT07036523·Phase 2·Recruiting·Listed Jun 2025
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
for Muscular Atrophy, Spinal
9 locations incl. Little Rock
Sponsor: Hoffmann-La Roche
Sex: All·Age: 3 Months - 24 Months
Code: NCT05861999·Phase 4·Recruiting·Listed May 2023
Showing the 40 most relevant of 227 recruiting trials at this site. Browse all with filters →
More research sites in Gainesville
- University of Florida (211 trials)
- UF Health Cancer Institute - Gainesville (44 trials)
- University of Florida Health (12 trials)
- North Florida/South Georgia Veterans Health System, Gainesville, FL (11 trials)
- University of Florida College of Medicine (9 trials)
- Malcom Randall Veterans Administration Medical Center (8 trials)
- Vitreo Retinal Associates (8 trials)
- UF Health (7 trials)
- UF Health Shands Hospital (6 trials)
- Norman Fixel Institute for Neurological Diseases (6 trials)
Explore more
Paid clinical trials in Gainesville, FL · Florida clinical trials